Mimi I-Nan Hu MD
Diabetes, Osteoporosis & Bone Metabolism Medicine, Parathyroid, Thyroid
Professor Endocrine Neoplasia and Hormonal Disorders The University of Texas MD Anderson Cancer Center
Join to View Full Profile
1515 Holcombe Blvd, Unit 1461Houston, TX 77030
Phone+1 713-792-2841
Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007- Baylor College of MedicineResidency, Internal Medicine, 2000 - 2004
McGovern Medical School at UTHealthClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2002 - 2026
WA State Medical License 2023 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Approach to the Patient: Hereditary Medullary Thyroid Carcinoma.Omair A Shariq, Steven G Waguespack, Sarah Hamidi, Benjamin C Kensing, Mimi I Hu
The Journal of Clinical Endocrinology and Metabolism. 2025-03-19 - 2 citationsClinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.Barbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, Mimi I Hu, Lori J Wirth
The Journal of Clinical Endocrinology and Metabolism. 2025-02-18 - Systemic Therapies for Advanced Medullary Thyroid Carcinoma.Marco Ruiz Santillan, Ramona Dadu, Robert F Gagel, Elizabeth G Grubbs, Mimi I Hu
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 2025-01-01
Press Mentions
Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024- Targeted Therapy Pralsetinib Safely Effectively Treats Lung and Thyroid Cancers with RET AlterationsJune 9th, 2021
- Gavreto Gets Accelerated Approval for RET-Altered Thyroid CancersDecember 3rd, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
